[go: up one dir, main page]

DK0550031T3 - Medical aerosol formulation - Google Patents

Medical aerosol formulation

Info

Publication number
DK0550031T3
DK0550031T3 DK92121985.3T DK92121985T DK0550031T3 DK 0550031 T3 DK0550031 T3 DK 0550031T3 DK 92121985 T DK92121985 T DK 92121985T DK 0550031 T3 DK0550031 T3 DK 0550031T3
Authority
DK
Denmark
Prior art keywords
aerosol formulation
medical aerosol
active substance
medical
medicinal
Prior art date
Application number
DK92121985.3T
Other languages
Danish (da)
Inventor
Claudia Schuetz
Hans-Matthias Dr Deger
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6448287&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0550031(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay filed Critical Solvay
Application granted granted Critical
Publication of DK0550031T3 publication Critical patent/DK0550031T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

A medicinal aerosol formulation which contains at least one medicinal active substance, at least one surface-active substance and pressure-liquefied heptafluoropropane as propellant is described. <IMAGE>
DK92121985.3T 1991-12-31 1992-12-24 Medical aerosol formulation DK0550031T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4143263 1991-12-31

Publications (1)

Publication Number Publication Date
DK0550031T3 true DK0550031T3 (en) 1996-08-26

Family

ID=6448287

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92121985.3T DK0550031T3 (en) 1991-12-31 1992-12-24 Medical aerosol formulation

Country Status (8)

Country Link
EP (1) EP0550031B1 (en)
JP (1) JPH05279249A (en)
AT (1) ATE137666T1 (en)
CA (1) CA2086492A1 (en)
DE (1) DE59206234D1 (en)
DK (1) DK0550031T3 (en)
ES (1) ES2089357T3 (en)
SG (1) SG42375A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (en) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS
DE59400836D1 (en) * 1993-01-19 1996-11-21 Hoechst Ag Liquid gas formulation for vitality testing of teeth
US5679287A (en) 1995-04-28 1997-10-21 Great Lakes Chemical Corporation Uses of heptafluoropropane
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6461591B1 (en) 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DE59911149D1 (en) 1998-07-24 2004-12-30 Jago Res Ag Muttenz MEDICAL AEROSOL FORMULATIONS
JP4672143B2 (en) 1998-08-04 2011-04-20 ヤゴテック アーゲー Pharmaceutical aerosol formulation
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
DE60042057D1 (en) * 1999-01-29 2009-06-04 Esperanza Peptide Ltd BUKKALES ADMINISTRATION SYSTEM FOR PROTEIN-CONTAINING MEDICAMENTS
PT1169019E (en) 1999-04-14 2003-07-31 Glaxo Group Ltd PHARMACEUTICAL FORMULA IN AEROSOL

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE3905726A1 (en) * 1989-02-24 1990-08-30 Hoechst Ag COMPRESSED GAS PACKING AND DRIVING AGENT FOR AEROSOLS
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ATE134509T1 (en) * 1991-06-10 1996-03-15 Schering Corp HYDROCHLOROFLUOROCARBON-FREE AEROSOL FORMULATIONS

Also Published As

Publication number Publication date
ES2089357T3 (en) 1996-10-01
EP0550031A1 (en) 1993-07-07
EP0550031B1 (en) 1996-05-08
JPH05279249A (en) 1993-10-26
ATE137666T1 (en) 1996-05-15
DE59206234D1 (en) 1996-06-13
CA2086492A1 (en) 1993-07-01
SG42375A1 (en) 2001-04-17

Similar Documents

Publication Publication Date Title
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
PT698393E (en) SOLUBILIZATION AGENT AND PREPARATION FOR EXTERNAL USE CONTAINING THE SAME
DE69132407D1 (en) AEROSOL MEDICAL FORMULATIONS
CA2004598A1 (en) Medicinal aerosol formulations
DK0553298T3 (en) Aerosol formulation comprising beclomethasone 17,21 dipropionate
EP1736147A3 (en) Non-chlorofluorocarbon aerosol formulations
ES2182357T3 (en) NEW USE OF BUDESONIDE AND FORMOTEROL.
DE69711637D1 (en) AEROSOL FORMULATIONS
DK0550031T3 (en) Medical aerosol formulation
ATE131730T1 (en) ANTI-VIRUS PREPARATIONS CONTAINING NUCLEOSIDE ANALOGUES
ES2093269T3 (en) MICROEMULSIONS OF THE WATER-IN-OIL TYPE.
MX9205384A (en) TRANSDERMIC ADMINISTRATION DEVICE OF AN ACTIVE AGENT FOR VETERINARY USE.
MC1265A1 (en) PREPARATION OF A PROSTAGLANDIN MEDICINAL PRODUCT
DK0626173T3 (en) Aerosol preparation containing fusafungin
GB2134783A (en) Medical preparation having antitumoral effect
ES2131482A1 (en) An aqueous formulation comprising bambuterol and the use thereof
ATE286716T1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING SALMETEROL
ITTO910597A1 (en) VACUUM EVAPORATION DOSAGE OF A DRUG AGENT, PARTICULARLY BERYLLIUM, AND PROCEDURE FOR CARRYING OUT THIS DRUG
GB2162746A (en) Antiacidotic medicinal agent